Print PDF

Sheppard Mullin Advises Advent MSO, COPE Health Solutions, Allied Universal And Others In Recent Deals

05.24.2022

Sheppard Mullin’s Corporate practice has been busy closing a variety of deals and transactions over the past few months:

Financings

  • Represented COPE Health Solutions, a leading technology-enabled products and services firm that helps healthcare providers and payers succeed with population health management and value-based payments, in connection with its $7.5 million Series A funding. Investors included global technology giant and digital partner Mindtree and New York-based MSO Solutions 4 Community Health. The deal team included John Hempill, Jay Gerzog and Karl Buhler. (April 19)

Mergers & Acquisitions

  • Represented Advent MSO, LLC in its acquisition of Ear Institutes, LLC, dba MN Ear & Sinus Center. Advent, an Excellere Capital Management, LLC portfolio company, is a management services organization that provides management, administrative and consulting services to otolaryngology physician practices in Illinois and Wisconsin. The deal team was led by Michael McKinnon and included Linda Igarashi, Dhara Waghela, Kara Du, Claudia Hinsch and John Crisp. (May 6)
  • Advised Allied Universal, the leading global security and facility services company, in its acquisition of Star Protection Agency, the largest locally-owned security firm in Hawaii. The deal was led by Stephen LaSala and Brandon Beshay (May 3). In addition, the firm advised the client in its acquisition of American Security, a top security provider in the Southeast region of the U.S. The deal team was led by LaSala, Beshay and Osama Khan. Special assistance was provided by Amy Tranckino, Kevin Cloutier, Michael Chan, Michael Weisshar and Kevin Ryan. (May 16)
  • Advised Comprehensive Spine and Sports Center (CSSC), in its sale to Integrated Pain Management (IPM), a Silver Oak Services Partners portfolio company. CSSC specializes in pain management procedures and therapies and provides physical rehabilitation services through 11 outpatient clinics throughout Northern California. The deal team was led by Michael McKinnon and included Bob Hogan, Annie Alvarado, Dhara Waghela Sheth, Lidore DeRose, Josh McLane, John Crisp, Michael Chan, Michael Weisshar, Erica Kraus, Mackenzie Wortley, Sara Shanti, Michael Sutton, Jason Weiss, Kristi Thomas and Molly Brooks. (May 10)
  • Represented Sentinel Offender Services, a portfolio company of Bison Capital Asset Management LLC, in its acquisition of Omnilink Systems Inc, a division of Sierra Wireless and provider of the industry-leading OM500 GPS electronic monitoring solution. The deal team was led by David Sands and Jeff Kaye, and included Gemma Descoteaux, Keith Gercken, Jason Mueller, Carrie McNally, Ken Peterson and Edward Xia. (April 18)

Public Offerings

  • Advised the Hoth Therapeutics, Inc. (NASDAQ: HOTH), clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs, in connection with a $7 million public offering of Common Stock. The deal team included Richard Friedman, Nazia Khan and Emily Mastoloni. (April 12)
  • Advised Ladenburg Thalmann & Co. Inc. as placement agent in connection with a $3.9 million registered direct offering of common stock and warrants of Philadelphia-based Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), a clinical-stage biopharmaceutical company. The deal team included Richard Friedman, Gregory Carney and Emily Mastoloni. (May 17)
  • Represented the underwriters in connection with a $5.8 million registered direct offering of common stock of Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The deal team included Richard Friedman and Emily Mastoloni. (April 14)
  • Represented OKYO Pharma Limited, (Nasdaq: OKYO, LSE: OKYO), a life sciences company developing next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases and ocular pain, in connection with its $2.5 million public offering. The deal team was led by Jeff Fessler and Hannah Zelcer. (May 19)
Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.